BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Hov JR, Boberg KM, Karlsen TH. Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol 2008; 14(24): 3781-3791 [PMID: 18609700 DOI: 10.3748/wjg.14.3781]
URL: https://www.wjgnet.com/1007-9327/full/v14/i24/3781.htm
(0) (0) (13371) (150)
Number Citing Articles
1
Manoj Thapa, Dana Tedesco, Sanjeev Gumber, Elizabeth J Elrod, Jin-Hwan Han, William H Kitchens, Joseph F Magliocca, Andrew B Adams, Arash Grakoui. Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver Disease. The Journal of Immunology 2020; 204(12) doi: 10.4049/jimmunol.1900391
2
Marco Vincenzo Lenti, Carlo Maria Rossi, Federica Melazzini, Matteo Gastaldi, Serena Bugatti, Mario Rotondi, Paola Ilaria Bianchi, Antonella Gentile, Luca Chiovato, Carlomaurizio Montecucco, Gino Roberto Corazza, Antonio Di Sabatino. Seronegative autoimmune diseases: A challenging diagnosis. Autoimmunity Reviews 2022; 21(9) doi: 10.1016/j.autrev.2022.103143
3
D. Robert Dufour. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 2012;  doi: 10.1016/B978-1-4160-6164-9.00050-0
4
Evaggelia Liaskou, Gideon M. Hirschfield, M. Eric Gershwin. Mechanisms of tissue injury in autoimmune liver diseases. Seminars in Immunopathology 2014; 36(5) doi: 10.1007/s00281-014-0439-3
5
David Tornai, Peter Laszlo Ven, Peter Laszlo Lakatos, Maria Papp. Serological biomarkers for management of primary sclerosing cholangitis. World Journal of Gastroenterology 2022; 28(21): 2291-2301 doi: 10.3748/wjg.v28.i21.2291
6
José Franco. Liver Disorders. 2017;  doi: 10.1007/978-3-319-30103-7_17
7
Pan Luo, Lin Liu, Weikun Hou, Ke Xu, Peng Xu, Nadeem Sheikh. Gene Set Enrichment Analysis Detected Immune Cell‐Related Pathways Associated with Primary Sclerosing Cholangitis. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/2371347
8
S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Zeitschrift für Gastroenterologie 2025; 63(06) doi: 10.1055/a-2558-5204
9
Matteo Bramuzzo, Stefano Martelossi, Giuliano Torre, Sabrina Cardile, Serena Arrigo, Silvia Vignola, Federica Ferrari, Giovanna Zuin, Maria Teresa Illiceto, Marco Gasparetto, Salvatore Pellegrino, Claudio Romano, Giuseppe Maggiore, Marcella Montico, Marina Aloi. Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(2) doi: 10.1097/MPG.0000000000001078
10
Dermot Gleeson, Rosemary Bornand, Ann Brownlee, Harpreet Dhaliwal, Jessica K Dyson, Janeane Hails, Paul Henderson, Deirdre Kelly, George F Mells, Rosa Miquel, Ye H Oo, Anthea Sutton, Andrew Yeoman, Michael A Heneghan. British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis. Gut 2025; 74(9) doi: 10.1136/gutjnl-2024-333171
11
Vincenzo Ronca, Maria-Carlota Londoño. Primary sclerosing cholangitis pathogenesis revisited: EBV-idence of immune dysregulation. JHEP Reports 2026; 8(3) doi: 10.1016/j.jhepr.2025.101665
12
Alpha Boubacar Conte, Fatoumata Coulibaly, Sofia Jayi, Fatima Zohra Fdili Alaoui, Hikmat Chaara, Moulay Abdelilah Melhouf. Primary sclerosing cholangitis revealed by pregnancy. Obstetrics & Gynecology International Journal 2023; 14(2) doi: 10.15406/ogij.2023.14.00695
13
Ida Schregel, Silja Steinmann, Christoph Schramm. Autoimmune Lebererkrankungen – ein Update (Teil 2). Gastroenterologie up2date 2022; 18(03) doi: 10.1055/a-1922-9264
14
Kirsten Muri Boberg, Roger W. Chapman, Gideon M. Hirschfield, Ansgar W. Lohse, Michael P. Manns, Erik Schrumpf. Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. Journal of Hepatology 2011; 54(2) doi: 10.1016/j.jhep.2010.09.002
15
A. Schreiber, B. Rudolph, A. Kahl, R. Kettritz. Akutes Nierenversagen bei einem lebertransplantierten Patienten. Der Nephrologe 2015; 10(5) doi: 10.1007/s11560-014-0932-7
16
Brian K. Chung, Gideon M. Hirschfield. Immunogenetics in primary sclerosing cholangitis. Current Opinion in Gastroenterology 2017; 33(2) doi: 10.1097/MOG.0000000000000336
17
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn, Mette Vesterhus. Primary sclerosing cholangitis – a comprehensive review. Journal of Hepatology 2017; 67(6) doi: 10.1016/j.jhep.2017.07.022
18
Dominik Roth, Miriam M Düll, Ludwig J Horst, Aylin Lindemann, Xenia Malzer, Kristina Koop, Sebastian Zundler, Marcel Vetter, André Jefremow, Raja Atreya, Carol Geppert, Sören Weidemann, Maximilian J Waldner, Peter Dietrich, Claudia Günther, Luis E Munoz, Martin Herrmann, Alexander Scheffold, Markus F Neurath, Jürgen Siebler, Christoph Schramm, Andreas E Kremer, Moritz Leppkes. Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2025; 19(2) doi: 10.1093/ecco-jcc/jjae131
19
Byoung Uk Park, Zongming Eric Chen. Practical Liver Pathology. Practical Anatomic Pathology 2025;  doi: 10.1007/978-3-031-97506-6_10
20
Shou-Pei Liu, Zhen-Hua Bian, Zhi-Bin Zhao, Jinjun Wang, Weici Zhang, Patrick S.C. Leung, Liang Li, Zhe-Xiong Lian. Animal Models of Autoimmune Liver Diseases: a Comprehensive Review. Clinical Reviews in Allergy & Immunology 2020; 58(2) doi: 10.1007/s12016-020-08778-6
21
Elisabeth M.G. de Vries, Ulrich Beuers, Cyriel Y. Ponsioen. Biomarkers for disease progression of primary sclerosing cholangitis. Current Opinion in Gastroenterology 2015; 31(3) doi: 10.1097/MOG.0000000000000163
22
Hiroyuki Isayama, Susumu Tazuma, Norihiro Kokudo, Atsushi Tanaka, Toshio Tsuyuguchi, Takahiro Nakazawa, Kenji Notohara, Suguru Mizuno, Nobuhisa Akamatsu, Masahiro Serikawa, Itaru Naitoh, Yoshiki Hirooka, Toshifumi Wakai, Takao Itoi, Tomoki Ebata, Shinji Okaniwa, Terumi Kamisawa, Hiroki Kawashima, Atsushi Kanno, Keiichi Kubota, Masami Tabata, Michiaki Unno, Hajime Takikawa. Clinical guidelines for primary sclerosing cholangitis 2017. Journal of Gastroenterology 2018; 53(9) doi: 10.1007/s00535-018-1484-9
23
Kayani Kayani, Amber G Bozward, Scott P Davies, Rebecca Jeyaraj, Ayma Asif, Ye H Oo. Encyclopedia of Immunobiology. 2026;  doi: 10.1016/B978-0-12-824465-4.00173-3
24
Laura Räisänen, Christopher Burgess, Fariha Balouch, Peter Lewindon. Proximally dominant inflammation at colonoscopy predicts pan-colonic histological remission following oral vancomycin therapy in pediatric ulcerative colitis. Digestive and Liver Disease 2026; 58(8) doi: 10.1016/j.dld.2026.06.001
25
Marcial Sebode, Heike Bantel, Ulrich Baumann, Philip Bufler, Münevver Demir, Leona Dold, Verena Keitel-Anselmino, Reinhild Klein, Andreas E. Kremer, Petra L. Jansen, Michael Melter, Peter Schirmacher, Christoph Schramm, Martina Sterneck, Christian P. Strassburg, Christina Weiler-Normann, Ansgar W. Lohse. Update der S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Living guideline. Zeitschrift für Gastroenterologie 2026; 64(05) doi: 10.1055/a-2769-2475
26
Takuma Misawa, Jeffrey A. SoRelle, Jin Huk Choi, Tao Yue, Kuan-wen Wang, William McAlpine, Jianhui Wang, Aijie Liu, Koichi Tabeta, Emre E. Turer, Bret Evers, Evan Nair-Gill, Subhajit Poddar, Lijing Su, Feiya Ou, Liyang Yu, Jamie Russell, Sara Ludwig, Xiaoming Zhan, Sara Hildebrand, Xiaohong Li, Miao Tang, Anne R. Murray, Eva Marie Y. Moresco, Bruce Beutler. Mutual inhibition between Prkd2 and Bcl6 controls T follicular helper cell differentiation. Science Immunology 2020; 5(43) doi: 10.1126/sciimmunol.aaz0085
27
Silja Steinmann, Ida Schregel, Christoph Schramm. Autoimmune Lebererkrankungen – ein Update (Teil 1). Gastroenterologie up2date 2022; 18(03) doi: 10.1055/a-1364-8489
28
James P. Stevens, Nitika A. Gupta. Recent Insights into Pediatric Primary Sclerosing Cholangitis. Clinics in Liver Disease 2022; 26(3) doi: 10.1016/j.cld.2022.03.009
29
William Balistreri, Simon Lam. Liver Disease in Children. 2021;  doi: 10.1017/9781108918978.021
30
Teresa Da Cunha, Haleh Vaziri, George Y. Wu. Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review. Journal of Clinical and Translational Hepatology 2022; 10(3) doi: 10.14218/JCTH.2021.00344
31
Priscila Menezes Ferri, Ana Cristina Simões e Silva, Soraya Luiza Campos Silva, Diego Junior Queiroga de Aquino, Eleonora Druve Tavares Fagundes, Débora Marques de Miranda, Alexandre Rodrigues Ferreira. The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/3905240
32
A. I. Parfenov, A. V. Kagramanova, O. V. Knyazev. Systemic manifestations of inflammatory bowel diseases. Terapevticheskii arkhiv 2020; 92(2) doi: 10.26442/00403660.2020.02.000535
33
Nina Barner-Rasmussen, Nelli Sjöblom, Johanna Arola, Sonja Boyd, Hannu Kautiainen, Martti Färkkilä. The role of serology, liver function tests and imaging in screening of primary sclerosing cholangitis: the HelPSCreen score. Scandinavian Journal of Gastroenterology 2023; 58(12) doi: 10.1080/00365521.2023.2233038
34
U. Spengler. Differenzialdiagnose Ikterus. Der Gastroenterologe 2010; 5(4) doi: 10.1007/s11377-009-0390-3
35
Rosanna Villani, Gaetano Serviddio, Carlo Avolio, Tommaso Cassano, Emanuele D’Amico. Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives. Clinical and Experimental Medicine 2023; 23(7) doi: 10.1007/s10238-023-01128-8
36
Paola De Angelis, Renato Tambucci, Erminia Romeo, Francesca Rea, Claudia Caloisi, Tamara Caldaro, Giovanni Federici di Abriola, Francesca Foschia, Filippo Torroni, L. Monti, Luigi Dall'Oglio. Does an isolated benign choledochal stricture hide a PSC?. Journal of Pediatric Surgery 2013; 48(5) doi: 10.1016/j.jpedsurg.2013.02.020
37
Vitantonio GUGLIELMI, Pietro GIORGIO, Vito GUERRA, Anna SONNANTE, Massimo TUTINO, Rossella DONGHIA, Antonio PISANI. Prognostic value of perinuclear antineutrophil cytoplasmic antibodies in subjects with primary sclerosing cholangitis. Minerva Medica 2022; 113(3) doi: 10.23736/S0026-4806.20.06604-5
38
Lena Berglin, Niklas K. Björkström, Annika Bergquist. Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells. Scandinavian Journal of Gastroenterology 2013; 48(6) doi: 10.3109/00365521.2013.786131
39
T. Liwinski, C. Schramm. Primär sklerosierende Cholangitis. Der Internist 2018; 59(6) doi: 10.1007/s00108-018-0428-z
40
Johannes R. Hov, Kirsten M. Boberg, Eli Taraldsrud, Mette Vesterhus, Maria Boyadzhieva, Inger Camilla Solberg, Erik Schrumpf, Morten H. Vatn, Benedicte A. Lie, Øyvind Molberg, Tom H. Karlsen. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis. Liver International 2017; 37(3) doi: 10.1111/liv.13238
41
Maria C. SORRENTINO, Teresa CARBONE, Luigi CINQUANTA, Maria G. ALESSIO, Maria INFANTINO, Gaia DELEONARDI, Maria T. TREVISAN, Brunetta PORCELLI, Lucia TERZUOLI, Stefan PLATZGUMMER, Ignazio BRUSCA, Antonio ANTICO, Marilina TAMPOIA, Giampaola PESCE, Danilo VILLALTA, Nicola BIZZARO. Linee guida SIPMeL per la determinazione degli autoanticorpi nella diagnosi delle malattie autoimmuni del fegato. La Rivista Italiana della Medicina di Laboratorio 2024; 20(1) doi: 10.23736/S1825-859X.24.00226-3
42
John M. Vierling. Primary Sclerosing Cholangitis. 2017;  doi: 10.1007/978-3-319-40908-5_9
43
Gary L. Norman, Nicola Bizzaro, Danilo Villalta, Diego Vergani, Giorgina Mieli-Vergani, Gideon M. Hirschfield, Michael Mahler. Precision Medicine and Artificial Intelligence. 2021;  doi: 10.1016/B978-0-12-820239-5.00012-7
44
Stefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, Michele Biagioli, Eleonora Distrutti. Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments. Cells 2024; 13(19) doi: 10.3390/cells13191650
45
Stefano Fiorucci, Silvia Marchianò, Ginevra Urbani, Cristina Di Giorgio, Eleonora Distrutti, Angela Zampella, Michele Biagioli. Immunology of bile acids regulated receptors. Progress in Lipid Research 2024; 95 doi: 10.1016/j.plipres.2024.101291
46
Dushyant Singh Dahiya, Hassam Ali, Bhanu Siva Mohan Pinnam, Purva Shah, SriLakshmiDevi Kanumilli, Angad Tiwari, Ernesto Calderon-Martinez, David Guevara-Lazo, Natalia Nombera-Aznaran, Yash R Shah. Liver transplant in primary sclerosing cholangitis: Current trends and future directions. World Journal of Hepatology 2023; 15(8): 939-953 doi: 10.4254/wjh.v15.i8.939
47
Rosebella A. Iseme, Mark McEvoy, Brian Kelly, Linda Agnew, Frederick R. Walker, Michael Boyle, John Attia. A Cross-Sectional Study of the Association between Autoantibodies and Qualitative Ultrasound Index of Bone in an Elderly Sample without Clinical Autoimmune Disease. Journal of Immunology Research 2018; 2018 doi: 10.1155/2018/9407971
48
Claudia O. Zein. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2013; 17(2) doi: 10.1016/j.cld.2012.11.003
49
Sergey Moiseev, Jan Willem Cohen Tervaert, Yoshihiro Arimura, Dimitrios P. Bogdanos, Elena Csernok, Jan Damoiseaux, Marc Ferrante, Luis Felipe Flores-Suárez, Marvin J. Fritzler, Pietro Invernizzi, David Jayne, J. Charles Jennette, Mark A. Little, Stephen P. McAdoo, Pavel Novikov, Charles D. Pusey, Antonella Radice, Alan D. Salama, Judith A. Savige, Mårten Segelmark, Yehuda Shoenfeld, Renato A. Sinico, Maria-José Sousa, Ulrich Specks, Benjamin Terrier, Athanasios G. Tzioufas, Severine Vermeire, Ming-Hui Zhao, Xavier Bossuyt. 2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmunity Reviews 2020; 19(9) doi: 10.1016/j.autrev.2020.102618
50
Kirsten Muri Boberg. Autoimmune Hepatitis. 2012;  doi: 10.1007/978-1-60761-569-9_12
51
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice. Clinical Reviews in Allergy & Immunology 2021; 63(2) doi: 10.1007/s12016-021-08888-9
52
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseases. Journal of Autoimmunity 2010; 34(3) doi: 10.1016/j.jaut.2009.12.002
53
Aalam Sohal, Sanya Kayani, Kris V. Kowdley. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2024; 28(1) doi: 10.1016/j.cld.2023.07.005
54
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. Journal of Hepatology 2009; 51(2) doi: 10.1016/j.jhep.2009.04.009
55
Sarajo Kumar Mohanta, Changjun Yin, Li Peng, Prasad Srikakulapu, Vineela Bontha, Desheng Hu, Falk Weih, Christian Weber, Norbert Gerdes, Andreas J.R. Habenicht. Artery Tertiary Lymphoid Organs Contribute to Innate and Adaptive Immune Responses in Advanced Mouse Atherosclerosis. Circulation Research 2014; 114(11) doi: 10.1161/CIRCRESAHA.114.301137
56
Keisuke Kakisaka, Kazuyuki Ishida, Kojiro Kataoka, Yuji Suzuki, Shunichi Yanai, Hidekatsu Kuroda, Tamotsu Sugai, Takayuki Matsumoto, Yasuhiro Takikawa. Reversible sclerosing cholangitis with ulcerative colitis. Pathology International 2016; 66(7) doi: 10.1111/pin.12427
57
Haiyan Zhang, Patrick S.C. Leung, M. Eric Gershwin, Xiong Ma. How the biliary tree maintains immune tolerance?. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4) doi: 10.1016/j.bbadis.2017.08.019
58
Zhengyang Miao, Hailin Chen, Yongming Zhou. Causal effect of primary sclerosing cholangitis on diffuse large B-cell lymphoma: A two-sample Mendelian randomized study. Medicine 2024; 103(47) doi: 10.1097/MD.0000000000040542
59
Brian K. Chung, Bardia T. Guevel, Gary M. Reynolds, D.B.R.K. Gupta Udatha, Eva Kristine Klemsdal Henriksen, Zania Stamataki, Gideon M. Hirschfield, Tom Hemming Karlsen, Evaggelia Liaskou. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis. Journal of Autoimmunity 2017; 77 doi: 10.1016/j.jaut.2016.10.003
60
K. Wiencke, K.M. Boberg. Current consensus on the management of primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology 2011; 35(12) doi: 10.1016/j.clinre.2011.04.007
61
Nora Cazzagon, Olivier Chazouillères. Diseases of the Liver and Biliary Tree. 2021;  doi: 10.1007/978-3-030-65908-0_11
62
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
63
Caterina Maria Gambino, Luisa Agnello, Vincenza Calvaruso, Rosaria Vincenza Giglio, Luigi Capodicasa, Concetta Scazzone, Giuseppina Candore, Fabio Del Ben, Vito Di Marco, Marcello Ciaccio. Prevalence and heterogeneity of antinuclear antibody patterns in adult Italian patients with autoimmune liver diseases: Our experience. Clinica Chimica Acta 2025; 566 doi: 10.1016/j.cca.2024.120037
64
Sang-Heum Park, Hoo Rim Song, Sung Won Lee, Tae Hoon Lee. Wouldn't Human Understanding be Necessary to Treat Patients with Pancreaticobiliary Disease More Effectively?. The Korean Journal of Pancreas and Biliary Tract 2018; 23(3) doi: 10.15279/kpba.2018.23.3.89
65
Ziwen Pan, Weijie Zhang. Causal relationship between primary sclerosing cholangitis and systemic lupus erythematosus: a bidirectional Mendelian randomization study. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-01941-1
66
Muneji Yasuda, Masahiro Shiokawa, Takeshi Kuwada, Yoshihiro Nishikawa, Risa Nakanishi, Ikuhisa Takimoto, Koki Chikugo, Masataka Yokode, Yuya Muramoto, Shimpei Matsumoto, Takeharu Nakamura, Sakiko Ota, Tomoaki Matsumori, Keiko Kuroda, Takahisa Hachiya, Hajime Yamazaki, Norimitsu Uza, Yuzo Kodama, Tsutomu Chiba, Toshio Fujisawa, Atsumasa Komori, Masanori Abe, Izumi Yamaguchi, Fumihiko Matsuda, Hiroyuki Isayama, Atsushi Tanaka, Hiroshi Seno. Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study. Journal of Gastroenterology 2025; 60(1) doi: 10.1007/s00535-024-02169-w
67
Beate Preuß, Amelie Frank, Birgit Terjung, Ulrich Spengler, Christoph Berg, Reinhild Klein. Autoantibodies to beta tubulin in autoimmune liver diseases—Relation to pANCA and clinical relevance. Clinical and Experimental Immunology 2024; 216(2) doi: 10.1093/cei/uxad114
68
Claudiu Marinel Ionele, Adina Turcu-Stiolica, Mihaela Simona Subtirelu, Bogdan Silviu Ungureanu, George Ovidiu Cioroianu, Ion Rogoveanu. A Systematic Review and Meta-Analysis on Metabolic Bone Disease in Patients with Primary Sclerosing Cholangitis. Journal of Clinical Medicine 2022; 11(13) doi: 10.3390/jcm11133807
69
Martin Cornillet, Aiva Lundberg Båve, Dan Sun, Ghada Nouairia, Christina Villard, Aristeidis Grigoriadis, Erik von Seth, Hannes Jansson, María Bueno Álvez, Sofia Bergström, Peter Nilsson, Mathias Uhlén, Fredrik Edfors, Per Stål, Mårten Werner, Nils Nyhlin, Fredrik Rorsman, Johan Vessby, Nilsson Emma, Antonio Molinaro, Annika Bergquist, Stergios Kechagias, Maria Antonella Burza, Lina Lindström, Ernesto Sparrelid, Niklas K. Björkström, Jonas Halfvarson, Annika Bergquist. Proteome-scale autoantibody profiling in PSC: Associations with clinical phenotypes and evidence for neuroendocrine deregulations. JHEP Reports 2026; 8(3) doi: 10.1016/j.jhepr.2025.101719
70
Johannes R. Hov, Tom H. Karlsen. The microbiota and the gut–liver axis in primary sclerosing cholangitis. Nature Reviews Gastroenterology & Hepatology 2023; 20(3) doi: 10.1038/s41575-022-00690-y
71
Evangelos Triantafyllou, Cathrin L. C. Gudd, Lucia A. Possamai. Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management. Nature Reviews Gastroenterology & Hepatology 2025; 22(2) doi: 10.1038/s41575-024-01019-7
72
Hyun Jin Cha, Jimin Hwang, Lucy Eunju Lee, Younhee Park, Jason Jungsik Song, Gianfranco D. Alpini. The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease. PLOS ONE 2021; 16(1) doi: 10.1371/journal.pone.0244950
73
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview. Journal of Autoimmunity 2018; 95 doi: 10.1016/j.jaut.2018.10.004
74
Mohammed Rifat Shaik, Hee Jae Jung, Nishat Anjum Shaik, Jamal Mikdashi. Diseases of the Gallbladder and the Biliary Tree in Systemic Lupus Erythematosus: Review of Clinical Presentation, Diagnosis and Management. Indian Journal of Rheumatology 2025; 20(2) doi: 10.1177/09733698241300754
75
Sigrid Næss, Alexey Shiryaev, Johannes R. Hov, Andre Franke, Tom H. Karlsen. Genetics in primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology 2012; 36(4) doi: 10.1016/j.clinre.2012.02.003
76
Dong Xi, Henry Lin, Amit A. Shah. Overview of autoimmune liver disease: Prevalence, risk factors, and role of autoantibodies. Clinical Liver Disease 2022; 20(4) doi: 10.1002/cld.1227
77
A. V. Nikitin, G. V. Volynets. Sclerosing cholangitis and inflammatory bowel disease: which comes first?. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2021; 66(1) doi: 10.21508/1027-4065-2021-66-1-39-46
78
Kai Markus Schneider, Martin Kummen, Palak J. Trivedi, Johannes R. Hov. Role of microbiome in autoimmune liver diseases. Hepatology 2024; 80(4) doi: 10.1097/HEP.0000000000000506
79
Brian K. Chung, Eva Kristine Klemsdal Henriksen, Kristin Kaasen Jørgensen, Tom H. Karlsen, Gideon M. Hirschfield, Evaggelia Liaskou. Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis–Inflammatory Bowel Disease. Hepatology Communications 2018; 2(8) doi: 10.1002/hep4.1200
80
Hyeok Choi, Yong-Beom Park, Jaewoo Song, Sang-Won Lee. Unclassifiable repeated antineutrophil cytoplasmic antibody (ANCA) positivity in diseases other than ANCA-associated vasculitis. Zeitschrift für Rheumatologie 2022; 81(8) doi: 10.1007/s00393-021-00998-1
81
Senka Dobric, Dragan Popovic, Milos Nikolic, Sladjana Andrejevic, Milan Spuran, Branka Bonaci-Nikolic. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis. Clinical Chemistry and Laboratory Medicine 2012; 50(3) doi: 10.1515/cclm.2011.797
82
Simona Marzorati, Pietro Invernizzi, Ana Lleo. Making Sense of Autoantibodies in Cholestatic Liver Diseases. Clinics in Liver Disease 2016; 20(1) doi: 10.1016/j.cld.2015.08.003
83
Albert Parés. Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamiento. Gastroenterología y Hepatología 2011; 34(1) doi: 10.1016/j.gastrohep.2010.02.006
84
Biljana Radovanović-Dinić, Snežana Tešić-Rajković, Valentina Zivkovic, Saša Grgov. Clinical connection between rheumatoid arthritis and liver damage. Rheumatology International 2018; 38(5) doi: 10.1007/s00296-018-4021-5
85
Tom H. Karlsen, Kirsten Muri Boberg, Erik Schrumpf. Zakim and Boyer's Hepatology. 2012;  doi: 10.1016/B978-1-4377-0881-3.00042-5
86
Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist, Mark Deneau, Lisa Forman, Sumera I. Ilyas, Keri E. Lunsford, Mercedes Martinez, Gonzalo Sapisochin, Rachna Shroff, James H. Tabibian, David N. Assis. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2023; 77(2) doi: 10.1002/hep.32771
87
Tom Hemming Karlsen, Gideon M. Hirschfield. Primary Sclerosing Cholangitis. 2017;  doi: 10.1007/978-3-319-40908-5_8
88
Hanh D. Vo, Jiliu Xu, Simon S. Rabinowitz, Stanley E. Fisher, Steven M. Schwarz. The Liver in Pediatric Gastrointestinal Disease. Journal of Pediatric Gastroenterology and Nutrition 2014; 59(3) doi: 10.1097/MPG.0000000000000444
89
Alexander Zipprich. Rheumatologie und Hepatologie: Diagnostik und Therapie von autoimmunen Lebererkrankungen. Aktuelle Rheumatologie 2021; 46(05) doi: 10.1055/a-0885-9314
90
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Liver Immunology. 2020;  doi: 10.1007/978-3-030-51709-0_4
91
Michal Prokopič, Ulrich Beuers. Management of primary sclerosing cholangitis and its complications: an algorithmic approach. Hepatology International 2021; 15(1) doi: 10.1007/s12072-020-10118-x
92
Ban‐Hock Toh. Diagnostic autoantibodies for autoimmune liver diseases. Clinical & Translational Immunology 2017; 6(5) doi: 10.1038/cti.2017.14
93
Antonio Di Sabatino, Federico Biagi, Marco Lenzi, Luca Frulloni, Marco Vincenzo Lenti, Paolo Giuffrida, Gino Roberto Corazza. Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases. Digestive and Liver Disease 2017; 49(9) doi: 10.1016/j.dld.2017.06.010
94
Haruka Okada, Shinya Sugimoto, Atsuto Kayashima, Yohei Mikami, Takanori Kanai, Nobuhiro Nakamoto, Yusuke Yoshimatsu, Hiroki Kiyohara, Yukie Nakadai, Ryosuke Kasuga, Nobuhito Taniki, Keisuke Ojiro, Shingo Usui, Shogo Sunaga, Ichiro Mizushima, Yuta Kaieda, Shohei Suzuki, Takaya Tabuchi, Makoto Ueno. Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease. Journal of Gastroenterology 2026; 61(7) doi: 10.1007/s00535-026-02388-3
95
Verghese George, Varaha Sairam Tammisetti, Venkateswar Rao Surabhi, Alampady K. Shanbhogue. Chronic Fibrosing Conditions in Abdominal Imaging. RadioGraphics 2013; 33(4) doi: 10.1148/rg.334125081
96
Henrike Lenzen, Tobias J. Weismüller, Ahmed A. Negm, Jenny Wlecke, Stephanie Loges, Christian P. Strassburg, Michael P. Manns, Tim O. Lankisch. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology 2013; 48(10) doi: 10.3109/00365521.2013.825313
97
E V Vinnitskaya, S R Abdulkhakov, D T Abdurakhmanov, R B Alikhanov, I G Bakulin, E A Belousova, A O Bueverov, E Z Burnevitch, M G Efanov, E Yu Eremina, T M Ignatova, L Yu Ilchenko, G G Karmazanovsky, O V Knyazev, Yu V Kulezneva, T N Lopatkina, T P Nekrasova, I G Nikitin, V V Pavlenko, A I Parfenov, S D Podymova, K L Raichelson, A R Reisis, R G Sayfutdinov, E V Skazyvaeva, V E Syutkin, S G Khomeriki, T Yu Haimenova, Yu G Sandler. Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018). Terapevticheskii arkhiv 2019; 91(2) doi: 10.26442/00403660.2019.02.000075
98
Umer Malik, Bilal Ashraf, Sonia B. Samuel, Stephen Hasak. GI Diseases Associated with Rheumatological and Vasculitic Conditions. Clinical Gastroenterology 2025;  doi: 10.1007/978-3-032-07868-1_12
99
Sina Fuchs, Monika Bayer, Richard Taubert, Michael P. Manns, Josef M. Pfeilschifter, Urs Christen, Edith Hintermann. Effects of adenovirus‐induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse model. Liver International 2019; 39(12) doi: 10.1111/liv.14183
100
Karam Karam, Johny Salem, Sarah Jalloul, Lynn Daoud, Pierre Hani. An occult primary sclerosing cholangitis unmasked by cholangiography: A case report. Medical Reports 2025; 9 doi: 10.1016/j.hmedic.2025.100168
101
Kazuhito Kawata, Yoshimasa Kobayashi, M. Eric Gershwin, Christopher L. Bowlus. The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Clinical Reviews in Allergy & Immunology 2012; 43(3) doi: 10.1007/s12016-012-8324-0
102
John E. Eaton, Jayant A. Talwalkar, Keith D. Lindor. The Autoimmune Diseases. 2014;  doi: 10.1016/B978-0-12-384929-8.00063-0
103
Sebastian Torben Jendrek, Daniel Gotthardt, Thomas Nitzsche, Laila Widmann, Tobias Korf, Maike Anna Michaels, Karl-Heinz Weiss, Evaggelia Liaskou, Mette Vesterhus, Tom Hemming Karlsen, Swantje Mindorf, Peter Schemmer, Florian Bär, Bianca Teegen, Torsten Schröder, Marc Ehlers, Christoph Matthias Hammers, Lars Komorowski, Hendrik Lehnert, Klaus Fellermann, Stefanie Derer, Johannes Roksund Hov, Christian Sina. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis. Gut 2017; 66(1) doi: 10.1136/gutjnl-2016-311739
104
Claudia O. Zein, Keith D. Lindor. Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Current Gastroenterology Reports 2010; 12(1) doi: 10.1007/s11894-009-0079-2
105
Roopa Hebbandi Nanjundappa, Kun Shao, Prasanna Krishnamurthy, M. Eric Gershwin, Patrick S.C. Leung, Channakeshava Sokke Umeshappa. Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications. Autoimmunity Reviews 2024; 23(2) doi: 10.1016/j.autrev.2023.103485
106
Erik von Seth, Tom H Karlsen, Atsushi Tanaka, Cyriel Ponsioen, Annika Bergquist. Primary sclerosing cholangitis. The Lancet 2026; 407(10538) doi: 10.1016/S0140-6736(25)02582-6
107
Joyce J B C van Beers, Ger H Koek, Jan G M C Damoiseaux. The Role of Autoantibodies in the Diagnosis of Autoimmune Liver Disease: Lessons Learned from Clinical Practice. The Journal of Applied Laboratory Medicine 2022; 7(1) doi: 10.1093/jalm/jfab099
108
Guilherme Grossi Lopes Cançado, Gideon M. Hirschfield. Management of primary sclerosing cholangitis: Current state-of-the-art. Hepatology Communications 2024; 8(12) doi: 10.1097/HC9.0000000000000590
109
José Franco. Pancreas and Biliary Disease. 2016;  doi: 10.1007/978-3-319-28089-9_14
110
Marcial Sebode, Christina Weiler-Normann, Timur Liwinski, Christoph Schramm. Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00609
111
Tamsin Cargill, Emma L. Culver. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.661196
112
Marcial Sebode, Lisa Schulz, Ansgar Lohse. “Autoimmune(-Like)” Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis. International Journal of Molecular Sciences 2017; 18(9) doi: 10.3390/ijms18091954
113
Janet Martin, Eleonora Petryayeva, Waliul I Khan. Autoantibodies in Common Connective Tissue Diseases: A Primer for Laboratory Professionals. The Journal of Applied Laboratory Medicine 2022; 7(1) doi: 10.1093/jalm/jfab131
114
Xiaojun Jiang, Tom H. Karlsen. Genetics of primary sclerosing cholangitis and pathophysiological implications. Nature Reviews Gastroenterology & Hepatology 2017; 14(5) doi: 10.1038/nrgastro.2016.154
115
Benedetta Terziroli Beretta‐Piccoli, Giorgina Mieli‐Vergani, Diego Vergani. Autoimmune Liver Disease. 2020;  doi: 10.1002/9781119532637.ch4
116
Bishoi Aziz, Beverley Kok, Matthew Cheah, Ellina Lytvyak, Carlos Moctezuma-Velazquez, Shawn Wasilenko, Emmanuel Tsochatzis, Reena Ravikumar, Sophie Jose, Michael Allison, Bridget Gunson, Derek Manas, Andrea Monaco, Darius Mirza, Giuseppe Fusai, Nicola Owen, Douglas Thorburn, Keith Roberts, Parthi Srinivasan, Stephen Wigmore, Anuja Athale, Felicity Creamer, Bimbi Fernando, Vikram Iyer, Mansoor Madanur, Gourab Sen, Aldo J. Montano-Loza, Bettina Hansen, Andrew L. Mason. Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation. American Journal of Gastroenterology 2025; 120(2) doi: 10.14309/ajg.0000000000002977
117
Kelly Hudspeth, Elena Pontarini, Paolo Tentorio, Matteo Cimino, Matteo Donadon, Guido Torzilli, Enrico Lugli, Silvia Della Bella, M. Eric Gershwin, Domenico Mavilio. The role of natural killer cells in autoimmune liver disease: A comprehensive review. Journal of Autoimmunity 2013; 46 doi: 10.1016/j.jaut.2013.07.003
118
You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis. Experimental & Molecular Medicine 2023; 55(7) doi: 10.1038/s12276-023-01042-9
119
Christopher L. Bowlus. Liver Immunology. 2014;  doi: 10.1007/978-3-319-02096-9_4
120
Shikib Mostamand, Shauna Schroeder, Jacqueline Schenkein, Tamir Miloh. Infliximab‐Associated Immunomediated Hepatitis in Children With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(1) doi: 10.1097/MPG.0000000000001137
121
Abin Chandrakumar, Rachael Loeppky, Mark Deneau, Wael El-Matary. Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels. The Journal of Pediatrics 2019; 215 doi: 10.1016/j.jpeds.2019.07.065
122
Andrzej Chruscinski, Stephen Juvet, Sajad Moshkelgosha, Eberhard Renner, Leslie Lilly, Nazia Selzner, Christopher Bredeson, David Grant, Oyedele Adeyi, Sandra Fischer, Anthony J. Demetris, Jianhua Zhang, Maor Epstein, Meaghan Macarthur, Anne Marie Clement, Korosh Khalili, David Allan, Sultan Altouri, Isabelle Bence-Bruckler, Mark Cattral, Jill Fulcher, Zita Galvin, Anand Ghanekar, Paul Greig, Lothar Huebsch, Atul Humar, Andrea Kew, Natasha Kekre, Tae Kyoung Kim, Sheryl McDiarmid, Lisa Martin, Ian McGilvray, Mitchell Sabloff, Gonzalo Sapisochin, Markus Selzner, Robert Smith, Kathryn Tinckam, Tae Joon Yi, Gary Levy, Harold Atkins. Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study. Transplantation 2022; 106(3) doi: 10.1097/TP.0000000000003829
123
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Clinical significance of autoantibodies in autoimmune hepatitis. Journal of Autoimmunity 2013; 46 doi: 10.1016/j.jaut.2013.08.001
124
Erik Schrumpf, Kirsten Muri Boberg, Tom H. Karlsen. Primary sclerosing cholangitis – the Norwegian experience. Scandinavian Journal of Gastroenterology 2015; 50(6) doi: 10.3109/00365521.2015.1028996
125
Channakeshava Sokke Umeshappa, Santiswarup Singha, Jesus Blanco, Kun Shao, Roopa Hebbandi Nanjundappa, Jun Yamanouchi, Albert Parés, Pau Serra, Yang Yang, Pere Santamaria. Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-09893-5
126
Laura Räisänen, Fariha Balouch, Claire Reilly, Christopher Burgess, Peter Lewindon. Oral vancomycin solution is superior to capsule in inducing clinical biomarker and endoscopic remission in children with atypical ulcerative colitis. British Journal of Clinical Pharmacology 2025;  doi: 10.1002/bcp.70121
127
C. Buffet. Cholangites sclérosantes. EMC - Hépatologie 2011; 26(1) doi: 10.1016/S1155-1976(11)50375-4
128
Johannes R Hov, Øyvind Molberg, Tom H Karlsen. Tubulin beta 5 is not the target of antineutrophil antibodies in primary sclerosing cholangitis. Clinical and Experimental Immunology 2024; 218(1) doi: 10.1093/cei/uxae053
129
Laura Räisänen, Fariha Balouch, Annette McLaren-Kennedy, Julia Elizabeth Clark, Peter Lewindon. Outcomes of oral vancomycin therapy in children with atypical ulcerative colitis with or without confirmed primary sclerosing cholangitis: a real-world observational study. BMJ Open Gastroenterology 2025; 12(1) doi: 10.1136/bmjgast-2024-001605
130
Niv Zmora, Lian Bannon, Roie Tzadok, Noy Nachmias, Haim Leibovitzh, Ehud Zigmond. Serum Anti-Saccharomyces cerevisiae Antibody Is Associated with Disease Severity in Patients with Primary Sclerosing Cholangitis. Digestive Diseases 2026; 44(3) doi: 10.1159/000552341
131
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Serology in autoimmune hepatitis: A clinical-practice approach. European Journal of Internal Medicine 2018; 48 doi: 10.1016/j.ejim.2017.10.006
132
Piotr Milkiewicz, Marcin Krawczyk, Ewa Wunsch, Cyriel Ponsioen, Gideon M. Hirschfield, Stefan G. Hubscher. Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in Management. Hepatology Communications 2020; 4(3) doi: 10.1002/hep4.1467
133
Bilal Ashraf, Dana Gornick, Wajeed Sumbal, Zainab Saeed, Ruben Peredo, Micheal Tadros. GI Diseases Associated with Rheumatological and Vasculitic Conditions. Clinical Gastroenterology 2025;  doi: 10.1007/978-3-032-07868-1_10
134
Yangfan Chen, Ruofei Chen, Haiyan Li, Zongwen Shuai. Clinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead. Immunologic Research 2025; 73(1) doi: 10.1007/s12026-025-09622-9
135
Maria Concetta Sorrentino, Danilo Villalta, Teresa Carbone, Maria Grazia Alessio, Maria Infantino, Luigi Cinquanta, Gaia Deleonardi, Stefan Platzgummer, Maria Teresa Trevisan, Giampaola Pesce, Brunetta Porcelli, Marilina Tampoia, Antonio Antico, Ignazio Brusca, Nicola Bizzaro. Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) guidelines on the use of autoantibody tests in the diagnosis of autoimmune liver diseases. Autoimmunity Reviews 2026; 25(7) doi: 10.1016/j.autrev.2026.104093
136
Nathalie Pena Polanco, Claudia Cottone, Kalyan Ram Bhamidimarri. PSC and Overlap Syndromes. Current Hepatology Reports 2020; 19(2) doi: 10.1007/s11901-020-00518-w
137
Jason B. Samarasena, Ke-Qin Hu. Hepatobiliary Manifestations of Gastrointestinal and Nutritional Disorders. Clinics in Liver Disease 2011; 15(1) doi: 10.1016/j.cld.2010.09.003
138
P. J. Trivedi, G. M. Hirschfield. Review article: overlap syndromes and autoimmune liver disease. Alimentary Pharmacology & Therapeutics 2012; 36(6) doi: 10.1111/j.1365-2036.2012.05223.x
139
Roger Chapman, Johan Fevery, Anthony Kalloo, David M. Nagorney, Kirsten Muri Boberg, Benjamin Shneider, Gregory J. Gores. Diagnosis and Management of Primary Sclerosing Cholangitis. Hepatology 2010; 51(2) doi: 10.1002/hep.23294
140
Samar H. Ibrahim, Keith D. Lindor. Current Management of Primary Sclerosing Cholangitis in Pediatric Patients. Pediatric Drugs 2011; 13(2) doi: 10.2165/11586500-000000000-00000
141
Elisabeth Krones, Ivo Graziadei, Michael Trauner, Peter Fickert. Evolving concepts in primary sclerosing cholangitis. Liver International 2012; 32(3) doi: 10.1111/j.1478-3231.2011.02607.x
142
Nora Cazzagon, Samantha Sarcognato, Elisa Catanzaro, Emanuela Bonaiuto, Matteo Peviani, Francesco Pezzato, Raffaella Motta. Primary Sclerosing Cholangitis: Diagnostic Criteria. Tomography 2024; 10(1) doi: 10.3390/tomography10010005
143
Tom H. Karlsen, Erik Schrumpf, Kirsten M. Boberg. Update on primary sclerosing cholangitis. Digestive and Liver Disease 2010; 42(6) doi: 10.1016/j.dld.2010.01.011
144
Krisztina Hagymási, Zsolt Tulassay. Review of overlap syndromes of autoimmune liver diseases. Difficulties in the diagnosis and treatment. Orvosi Hetilap 2013; 154(24) doi: 10.1556/OH.2013.29640
145
Klaus Felix, Oliver Hauck, Martina Schnölzer, Tore Kempf, Uwe Warnken, Kathrin Schneider, Frank Bergmann, Stefan Fritz, Jens Werner. Identification of Novel Serum Autoantibodies for Differential Diagnosis of Autoimmune Pancreatitis and Pancreatic Ductal Adenocarcinoma. Pancreas 2016; 45(9) doi: 10.1097/MPA.0000000000000647
146
Tom Hemming Karlsen, Kirsten Muri Boberg. Sherlock's Diseases of the Liver and Biliary System. 2018;  doi: 10.1002/9781119237662.ch18
147
Christopher L. Bowlus. Liver Immunology. 2020;  doi: 10.1007/978-3-030-51709-0_25
148
Stella Gabeta, George N. Dalekos, Nikolaos K. Gatselis. Management of asymptomatic patients with abnormal liver function tests. European Journal of Internal Medicine 2025; 141 doi: 10.1016/j.ejim.2025.07.025
149
Naomi Richardson, Sky T. H. Ng, David C. Wraith. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01586
150
Olivier Chazouilleres, Ulrich Beuers, Annika Bergquist, Tom Hemming Karlsen, Cynthia Levy, Marianne Samyn, Christoph Schramm, Michael Trauner. EASL Clinical Practice Guidelines on sclerosing cholangitis. Journal of Hepatology 2022; 77(3) doi: 10.1016/j.jhep.2022.05.011
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.